"The California Institute for Regenerative Medicine is a world leader in funding stem cell research," said Bob Palay , Chairman and Chief Executive Officer of CDI. "Their human IPSC banking initiative will create the world's largest human iPSC bank. We are excited about receiving these grant awards. We see them as a validation of CDI's iCell® operating system as the premier platform for high quality human iPSCs and differentiated cells."
"Coriell Institute has established expertise in iPSC technology for several years now, and this award will expand our presence in the field considerably," said Michael Christman , Ph.D., President and CEO of Coriell. "We've also determined the best practices in biobanking during our 60 years of operations, managing millions of biological specimen for research discovery around the globe. We see the vast research potential with iPSCs and are enthusiastic about partnering with an outstanding company like CDI which is a world leader in the field."
Tom Novak , CDI Vice President of Strategic Partnerships, said, "We are delighted to be partnering with Coriell Institute to build and operate the CIRM human iPSC biobank. Together we intend to set high quality standards for the biobank to ensure that it meets the needs of the research community. Our work at CDI is focused on applying stem cell technology to impact human health today. Toward that end we developed the episomal reprogramming method to ensure that the resulting iPSCs are free of exogenous DNA, and this CIRM grant validates that method as researchers worldwide will access the resulting iPSC lines for disease research. We've concentrated our efforts on manufacturing hum
|SOURCE Cellular Dynamics International, Inc.|
Copyright©2012 PR Newswire.
All rights reserved